文献速递白血病MDS 与骨髓增殖性肿瘤

髓系恶性肿瘤中的黏连蛋白复合体突变

Cohesin mutations in myeloid malignancies.
PubMed 文献 · Blood · 2021-01-01

黏连蛋白复合体对姐妹染色单体黏连、染色质组织和转录调控至关重要,其核心亚基及调节因子在髓系肿瘤中反复突变。本文综述黏连蛋白在正常与恶性造血中的作用,讨论其临床意义及治疗靶向机会。

要点

  • 黏连蛋白核心亚基及调节因子在髓系肿瘤中反复突变。
  • 突变谱覆盖儿童唐氏综合征相关急性巨核细胞白血病至继发性AML。
  • 黏连蛋白突变驱动克隆扩增与疾病进展的机制尚不清楚。

核心结论

  • 黏连蛋白复合体突变在髓系恶性肿瘤中反复出现,但其驱动克隆扩增和疾病进展的机制仍不清楚。

研究设计与样本

  • 综述类文章,回顾黏连蛋白复合体在正常与恶性造血中的作用。

主要发现

  • 黏连蛋白核心亚基STAG2、RAD21、SMC1、SMC3及调节因子PDS5A/B、WAPL、NIPBL在血液和实体恶性肿瘤中反复突变。
  • 黏连蛋白突变见于全部髓系肿瘤谱系,包括儿童唐氏综合征相关急性巨核细胞白血病、MDS、CMML及原发和继发性AML。
  • 近期研究描述了黏连蛋白改变对造血干祖细胞自我更新和分化的影响,与染色质和表观遗传状态变化相关,并影响基因组完整性。

临床怎么用

  • 黏连蛋白突变可作为髓系肿瘤克隆扩增和疾病进展的潜在驱动因素进行认识。
  • 关注黏连蛋白改变对造血干祖细胞自我更新和分化的影响。
  • 探讨针对黏连蛋白突变的治疗靶向机会。

局限性

  • 黏连蛋白突变驱动克隆扩增和疾病进展的机制仍知之甚少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cohesin is a multisubunit protein complex that forms a ring-like structure around DNA. It is essential for sister chromatid cohesion, chromatin organization, transcriptional regulation, and DNA damage repair and plays a major role in dynamically shaping the genome architecture and maintaining DNA integrity. The core complex subunits STAG2, RAD21, SMC1, and SMC3, as well as its modulators PDS5A/B, WAPL, and NIPBL, have been found to be recurrently mutated in hematologic and solid malignancies. These mutations are found across the full spectrum of myeloid neoplasia, including pediatric Down syndrome-associated acute megakaryoblastic leukemia, myelodysplastic syndromes, chronic myelomonocytic leukemia, and de novo and secondary acute myeloid leukemias. The mechanisms by which cohesin mutations act as drivers of clonal expansion and disease progression are still poorly understood. Recent studies have described the impact of cohesin alterations on self-renewal and differentiation of hematopoietic stem and progenitor cells, which are associated with changes in chromatin and epigenetic state directing lineage commitment, as well as genomic integrity. Herein, we review the role of the cohesin complex in healthy and malignant hematopoiesis. We discuss clinical implications of cohesin mutations in myeloid malignancies and discuss opportunities for therapeutic targeting.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Jann JC, Tothova Z. Cohesin mutations in myeloid malignancies. Blood. 2021. PMID: 34157074. doi:10.1182/blood.2019004259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。